Radiation Oncology/Therapy: Page 5

ASTRO: SBRT effective in older patients with inoperable kidney tumors

By Will Morton

Stereotactic body radiation therapy (SBRT) offers a new treatment option for older patients with inoperable kidney tumors.

October 2, 2023

ASTRO: Short-course radiation is effective after mastectomy

By Kate Madden Yee

A short-course radiation protocol is effective for women who have undergone implant-based breast reconstruction after mastectomy, according to recent research.

October 2, 2023

ASTRO: Short radiation treatment for prostate cancer proves effective

By Kate Madden Yee

Men with intermediate risk, localized prostate cancer can be treated effectively with fewer and higher doses of stereotactic body radiation therapy (SBRT) over five treatment sessions.

October 2, 2023

IAEA's Rays of Hope initiative establishes anchor centers

By Will Morton

Rays of Hope – the International Atomic Energy Agency's (IAEA) flagship cancer initiative – has named inaugural "anchor centers" in five countries.

September 29, 2023

Radiation Oncology access program reduces racial disparities

By Amerigo Allegretto

Researchers are highlighting the success of a same-day radiation oncology access initiative that reduced racial disparities.

September 18, 2023

Tailored SABR for lung cancer reduces radiation dose

By Kate Madden Yee

Tailored SABR for lung cancer translates to lower radiation dose.

September 14, 2023

FAPI-PET/CT may improve treatment of cancer patients

By Will Morton

Gallium-68 (Ga-68) FAPI-PET/CT imaging -- a highly accurate experimental approach for detecting cancer -- may further improve outcomes for patients undergoing radiation therapy, according to a recent analysis by German researchers.

September 11, 2023

Eczacıbaşı-Monrol to expand Lu-177 production

By AuntMinnie.com staff writers

Turkish radiopharmaceutical company Eczacıbaşı-Monrol plans to expand its Lutetium-177 (Lu-177) production capacity.

September 10, 2023

Blue Earth highlights prostate cancer preclinical results

By AuntMinnie.com staff writers

Blue Earth Therapeutics is highlighting results from a preclinical study evaluating the efficacy of Ac-225 rhPSMA-10.1 compared with Lu-177 rhPSMA-10.1 for the treatment of prostate cancer.

September 10, 2023

ASTRO president speaks at cancer panel

By AuntMinnie.com staff writers

Jeff Michalski, MD, president of the American Society for Radiation Oncology (ASTRO), spoke at the recent President's Cancer Panel, part of the Biden Administration's National Cancer Plan.

September 6, 2023

Actinium to present three abstracts at SOHO 2023

By AuntMinnie.com staff writers

Radiotherapy developer Actinium Pharmaceuticals will present three abstracts accepted for poster presentation at the Society of Hematologic Oncology (SOHO) 2023 annual meeting in Houston, TX, between September 6 and 9.

August 30, 2023

TerraPower, PanTera sign agreement for Ac-225 production

By AuntMinnie.com staff writers

TerraPower Isotopes and PanTera signed a strategic collaboration that they say will increase the global availability of actinium-225 (Ac-225), a radioisotope that may prove able to treat a large variety of cancer indications.

August 30, 2023

Previous Page

Page 5 of 464

Next Page